These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 756707)

  • 1. [Skin tests of delayed hypersensitivity (tuberculin, DNCB) in the immunologic study of patients with primary cancer of the lung].
    Bariffi F; Illiano A; Tranfa CM; Del Prato B
    Arch Monaldi; 1978; 33(4):239-50. PubMed ID: 756707
    [No Abstract]   [Full Text] [Related]  

  • 2. [Skin reactions of delayed hypersensitivity in melanoblastoma].
    Ryzhkov VI; Potapenkova LS; Korosteleva TA; Khachaturian LM
    Vopr Onkol; 1979; 25(4):3-6. PubMed ID: 433214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Delayed hypersensitivity response of the skin to 2,4-dinitrochlorobenzene and old tuberculin in patients with lung cancer].
    Fan XJ
    Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):333-6. PubMed ID: 6653356
    [No Abstract]   [Full Text] [Related]  

  • 4. [Delayed hypersensitivity tests: PPD, DNCB and distreptase in patients with primary lung cancer].
    Słowik-Gabryelska A; Krzyśko R; Menzel-Czapiewska A; Lukaszewicz M; Gizycka D
    Pol Tyg Lek; 1978 Aug; 33(33):1299-302. PubMed ID: 704429
    [No Abstract]   [Full Text] [Related]  

  • 5. [Methyl heptine carbonate skin test in lung cancer--correlation with stage and prognosis].
    Takanami I; Nakayama H; Ishihara T; Yanai N
    Gan No Rinsho; 1984 Apr; 30(4):340-3. PubMed ID: 6727035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Delayed skin hypersensitivity to 2,4-dinitrochlorobenzene (DNCB) in patients with bronchial carcinoma].
    Ruszel KB
    Wiad Lek; 1978 Oct; 31(19):1341-4. PubMed ID: 716404
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of immune status in a surgical milieu. Correlation and complementarity of DNCB and multipuncture apropos of 101 patients].
    Champault G; Lesaget F; Biron G; Defayolle M; Roumiantzeff M; Boutelier P
    Med Chir Dig; 1982; 11(1):9-12. PubMed ID: 7087578
    [No Abstract]   [Full Text] [Related]  

  • 9. [The DNCB test in pneumology].
    Polistina D
    Arch Monaldi; 1977; 32(3):15-8. PubMed ID: 616268
    [No Abstract]   [Full Text] [Related]  

  • 10. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
    Lipenský R; Urban K
    Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
    [No Abstract]   [Full Text] [Related]  

  • 11. Delayed hypersensitivity in patients with bronchial carcinoma.
    Pauwels R; van der Straeten M
    Scand J Respir Dis; 1975 Sep; 56(3):160-4. PubMed ID: 1162307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [2,4-dinitrochlorobenzene skin test as an index of the primary cellular immunological response in skin diseases and syphilis].
    Fedotov VP; Lesnitskiĭ AI; Logunov VP; Manuĭlova LA; Zheliaz EV
    Vestn Dermatol Venerol; 1981; (10):7-12. PubMed ID: 7303876
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunologic defects in lung cancer patients.
    Holmes EC; Golub SH
    J Thorac Cardiovasc Surg; 1976 Feb; 71(2):161-8. PubMed ID: 1107678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative DNCB skin test in cancer patients.
    Dutta TK; Sengputa U; Gupta BD
    Indian J Cancer; 1977 Dec; 14(4):351-3. PubMed ID: 612559
    [No Abstract]   [Full Text] [Related]  

  • 15. Some aspects of cell-mediated hypersensitivity in patients with melanoma.
    Moszkowska G; Jassem J; Kondrat W; Kopacz A; Goszczyńska E
    Arch Immunol Ther Exp (Warsz); 1980; 28(4):655-60. PubMed ID: 6970028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients.
    Bolton PM
    Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cutaneous delayed hypersensitivity to costus root oil in lung cancer].
    Takanami I; Ishihara T; Yanai N
    Gan No Rinsho; 1985 Sep; 31(11):1362-6. PubMed ID: 4068238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cellular immunity indices in primary cancer and nontumorous diseases of the liver].
    Komissarenko VG; Shaĭn AA
    Vopr Onkol; 1981; 27(1):36-40. PubMed ID: 6969949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behavior of DNCB and tuberculin skin tests in relation to the various histological types of pulmonary cancer].
    Soresi V; Invernizzi G; Schiraldi G; Borghini U; Sacerdoti C; Maruzzi M
    Boll Ist Sieroter Milan; 1981 Jul; 60(3):216-21. PubMed ID: 6275868
    [No Abstract]   [Full Text] [Related]  

  • 20. [A study on immunological skin reactions in patients with active pulmonary tuberculosis. Clinical significance of the reduction of DNCB reaction in patients with active pulmonary tuberculosis].
    Ishibashi J
    Kekkaku; 1982 Dec; 57(12):665-70. PubMed ID: 7182645
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.